Association of age (elderly) with types of comorbidities and medications
| Comorbidities/medication | Elderly | p Value* | |
|---|---|---|---|
| Yes | No | ||
| Hypertension | 0.458† | ||
| Yes | 34 (61.8%) | 90 (54.9%) | |
| No | 21 (38.2%) | 74 (45.1%) | |
| Diabetes mellitus | 0.173† | ||
| Yes | 21 (38.2%) | 82 (50.0%) | |
| No | 34 (61.8%) | 82 (50.0%) | |
| Hyperlipidaemia | 0.613† | ||
| Yes | 30 (54.5%) | 81 (49.4%) | |
| No | 25 (45.5%) | 83 (50.6%) | |
| Depression | 0.683‡ | ||
| Yes | 1 (1.8%) | 6 (3.7%) | |
| No | 54 (98.2%) | 158 (96.3%) | |
| Ischaemic heart disease | 0.025† | ||
| Yes | 10 (18.2%) | 11 (6.7%) | |
| No | 45 (81.8%) | 153 (93.3%) | |
| Benign prostatic hyperplasia | <0.001† | ||
| Yes | 43 (50.9%) | 33 (20.1%) | |
| No | 27 (49.1%) | 131 (79.9%) | |
| Obesity | 0.005† | ||
| Yes | 3 (13.0%) | 40 (48.8%) | |
| No | 20 (87.0%) | 42 (51.2%) | |
| LUTS | 0.006‡* | ||
| Yes | 12 (21.8%) | 12 (7.3%) | |
| No | 43 (78.2%) | 152 (92.7%) | |
| No. of comorbidities | 0.650§ | ||
| None | 3 (5.5%) | 23 (14.5%) | |
| One | 9 (16.4%) | 24 (14.6%) | |
| Two | 10 (18.2%) | 33 (20.1%) | |
| Three | 20 (36.4%) | 49 (29.9%) | |
| Four | 12 (21.8%) | 29 (17.7%) | |
| Five | 1 (1.8%) | 5 (3.0%) | |
| Six | 0 (0.0%) | 1 (0.6%) | |
| Diabetic agents | 0.054§ | ||
| Oral agents | 35 (63.6%) | 85 (51.8%) | |
| Insulin | 18 (32.7%) | 56 (34.1% | |
| Insulin and oral agents | 2 (3.6%) | 4 (2.4%) | |
| No | 0 (0.0%) | 19 (3.6%) | |
| Antihypertensive agents | 0.595† | ||
| Yes | 33 (61.1%) | 92 (52.8%) | |
| No | 21 (38.9%) | 73 (44.2%) | |
| Lipid lowering agents | 0.502† | ||
| Yes | 28 (50.9%) | 94 (57.3%) | |
| No | 27 (49.1%) | 70 (42.7%) | |
| Antiplatelet agents | 0.164† | ||
| Yes | 41 (74.5) | 138 (84.1%) | |
| No | 12 (21.8) | 26 (15.9%) | |
| Antidepressants | 0.683‡ | ||
| Yes | 54 (98.2%) | 157 (95.7%) | |
| No | 1 (1.8%) | 7 (4.3%) | |
| Bronchodilator agents | 0.867† | ||
| Yes | 0 (0.0%) | 8 (4.9%) | |
| No | 55 (100.0%) | 156 (95.1%) | |
| α-Blockers | <0.001†* | ||
| Yes | 28 (51.9) | 26 (15.8) | |
| No | 26 (48.1) | 139 (84.2) |
LUTS, lower urinary tract symptom.
*χ2, significance level at p<0.05.
†Continuity correction.
‡Fisher's exact test.
§Pearson's χ2; statistically significant (p<0.05).